CUMYL-PEGACLONE
|
CUMYL-PEGACLONE
5-pentyl-2-(2-phenylpropan-2-yl)-2,5-dihydro-1H-pyrido[4,3-b]indol-1-one SGT-151 |
|
| 5-pentyl-2-(2-phenylpropan-2-yl)-2,5-dihydro-1H-pyrido[4,3-b]indol-1-one | |
| Synthetic cannabinoids | |
| Synthetic cannabinoid receptor agonists |
|
| 2160555-55-3 | |
|
|
InChI=1S/C25H28N2O/c1-4-5-11-17-26-21-15-10-9-14-20(21)23-22(26)16-18-27(24(23)28)25(2,3)19-12-7-6-8-13-19/h6-10,12-16,18H,4-5,11,17H2,1-3H3
|
|
AWHWTKXMUJLSRM-UHFFFAOYSA-N
|
|
|
O=C1N(C(C2=CC=CC=C2)(C)C)C=CC(N3CCCCC)=C1C4=C3C=CC=C4
|
|
| C25H28N2O | |
| 372.5026 g/mol | |
| 71/II | |
| 2021 | |
|
This substance is included in Schedule II of the 1971 Convention on Psychotropic Substances.
|